2 Healthcare Stocks That Could Go Parabolic
Investors have moved to higher ground, deserting growth stocks in exchange for large, stable companies. Maker of genetic testing kits for a multitude of rare diseases across multiple medical specialties — from ophthalmology to nephrology, and most organ systems in between — Invitae (NYSE: NVTA) has been hit hard lately. Invitae has ridden the personalized medicine wave and is firing on all cylinders.
Leave a Reply